Kalorama Information estimates that the global market for sepsis diagnostics reached approximately $1.3 billion in 2025, reflecting the enormous clinical and economic weight sepsis places on global healthcare. Yet despite steady growth and widespread use of diagnostic tools, sepsis is persistently one of the most difficult conditions to identify and manage. That reality is underscored […]
The NIH’s growing emphasis on New Approach Methodologies (NAMs) marks a significant change in how biomedical research, particularly drug development, is being conducted. Prompted by legislative changes, evolving regulatory guidance, and long-standing concerns about the ethics and limits of animal models, NAMs are increasingly being used to study drug safety, pharmacology, and biological mechanisms using […]
According to Kalorama Information, the IVD market is $113 billion. As Kalorama releases its 18th edition of the Worldwide Market for In Vitro Diagnostic Tests, the IVD market is experiencing moderate-level growth. These are the main factors that will shape markets right now in IVD. Some will drive growth and others will limit growth. Some […]
Pharmacodiagnostics is swiftly emerging as a vital player in the global cancer diagnostics market, which soared to nearly $10 billion in revenue in 2024, according to Kalorama Information’s recent report, The World Market for Cancer Diagnostics, 2024-2029. This dynamic sub-segment is experiencing rapid growth, fueled by the increasing affordability of next-generation sequencing (NGS), which offers profound […]
This blog draws on insights from the Kalorama Information report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. For further details, please visit the report’s product page HERE. Personalized medicine, also known as precision medicine, is revolutionizing the healthcare landscape. This innovative approach tailors medical treatment to the individual characteristics of […]
Welcome to our latest blog, created in collaboration with The Scott Partnership Ltd., a renowned UK-based global marketing and communications agency specializing in the life sciences, healthcare, and technology sectors. Originally published on their platform, this blog marks the beginning of an exciting ongoing partnership with more blogs to come. In Vitro Diagnostics Business Outlook’s […]
In 2023, point-of-care (POC) diagnostic testing market sales reached $36.8 billion, fueled by both professional and self-testing, according to Kalorama Information’s April 2024 report The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. The POC diagnostic testing market continues to expand thanks to emerging technologies and increasing demand that will drive growth into the […]
The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]
In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]
South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]
